House Democrats fail to advance drug pricing bill after feud with centrists

House Democrats failed to advance a consequential drug price negotiation measure out of committee on Wednesday after three centrists opposed the progressive agenda item.
Reps. Scott Peters of California and Kurt Schrader of Oregon, both Democrats who unveiled rival legislation Tuesday, voted against the measure, as did New York Democratic Rep. Kathleen Rice. With all Republicans voting no, the final vote was 29–29. The proposal was meant to be a key provision within the broader partisan Democratic multitrillion-dollar infrastructure and social welfare reconciliation bill.
Energy and Commerce Committee Chairman Frank Pallone pleaded with members on the fence to cast a vote in favor of advancing the proposal, which would give the federal government negotiating power with drug manufacturers for the highest priced and most commonly …

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Send this to a friend